Comment on “Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma”
Gespeichert in:
| Veröffentlicht in: | Contact dermatitis 2022-10, Vol.87 (4), p.387-388 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 388 |
|---|---|
| container_issue | 4 |
| container_start_page | 387 |
| container_title | Contact dermatitis |
| container_volume | 87 |
| creator | Ruan, Yeping Shih, Yanting Chen, Shile Xia, Qunli Zhao, Xiaoqing Cao, Hua |
| description | |
| doi_str_mv | 10.1111/cod.14179 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2710012300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2710012300</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3539-b69f3c0f302b511ac6e566dcd613660a3bd42c90d0b32110a53d35a1b0f53bec3</originalsourceid><addsrcrecordid>eNp1kL1OwzAURi0EoqUw8ALIEhND2us4dpsRlV-pUpcyR47tlFRx3NqNoEx9EHi5PgmmKWzc5S7n-67uQeiSQJ-EGUir-iQhw_QIdQkHiIBRfoy6QIBFZDSkHXTm_QKA8CQenaIOZUMeU0i6aDW2xuh6jW2Nd9vPmX0vJdbLUmlnRIVrLZ2tNr70WDWurOdYCuN0VX40RuR47bRY7-OFddhqb5evYq5D0K8aYWzjsdRVFUJOlrU1Yrf9Okcnhai8vjjsHnp5uJ-Nn6LJ9PF5fDuJJGU0jXKeFlRCQSHOGSFCcs04V1JxQjkHQXOVxDIFBTmNCQHBqKJMkBwKRnMtaQ9dt71LZ1eN9utsYRtXh5NZPCTBRRAAgbppqfCn904X2dKVRrhNRiD7kZsFudlebmCvDo1NbrT6I39tBmDQAm9lpTf_N2Xj6V1b-Q1ny4bR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2710012300</pqid></control><display><type>article</type><title>Comment on “Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma”</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Ruan, Yeping ; Shih, Yanting ; Chen, Shile ; Xia, Qunli ; Zhao, Xiaoqing ; Cao, Hua</creator><creatorcontrib>Ruan, Yeping ; Shih, Yanting ; Chen, Shile ; Xia, Qunli ; Zhao, Xiaoqing ; Cao, Hua</creatorcontrib><identifier>ISSN: 0105-1873</identifier><identifier>EISSN: 1600-0536</identifier><identifier>DOI: 10.1111/cod.14179</identifier><identifier>PMID: 35762304</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Antibodies, Monoclonal, Humanized ; anti‐PD1 immunotherapy ; anti‐SSA antibody ; Dermatitis, Allergic Contact ; Esophageal Neoplasms - drug therapy ; Esophageal Squamous Cell Carcinoma - drug therapy ; Humans ; immune checkpoint inhibitors ; Monoclonal antibodies ; Ro‐52 ; Squamous cell carcinoma ; Stevens-Johnson Syndrome - etiology ; Toxic epidermal necrolysis</subject><ispartof>Contact dermatitis, 2022-10, Vol.87 (4), p.387-388</ispartof><rights>2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</rights><rights>2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3539-b69f3c0f302b511ac6e566dcd613660a3bd42c90d0b32110a53d35a1b0f53bec3</citedby><cites>FETCH-LOGICAL-c3539-b69f3c0f302b511ac6e566dcd613660a3bd42c90d0b32110a53d35a1b0f53bec3</cites><orcidid>0000-0002-9232-1412 ; 0000-0001-5908-6206 ; 0000-0001-8090-0647 ; 0000-0001-5548-5883 ; 0000-0002-3825-9662 ; 0000-0001-8550-8767</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcod.14179$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcod.14179$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35762304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ruan, Yeping</creatorcontrib><creatorcontrib>Shih, Yanting</creatorcontrib><creatorcontrib>Chen, Shile</creatorcontrib><creatorcontrib>Xia, Qunli</creatorcontrib><creatorcontrib>Zhao, Xiaoqing</creatorcontrib><creatorcontrib>Cao, Hua</creatorcontrib><title>Comment on “Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma”</title><title>Contact dermatitis</title><addtitle>Contact Dermatitis</addtitle><subject>Antibodies, Monoclonal, Humanized</subject><subject>anti‐PD1 immunotherapy</subject><subject>anti‐SSA antibody</subject><subject>Dermatitis, Allergic Contact</subject><subject>Esophageal Neoplasms - drug therapy</subject><subject>Esophageal Squamous Cell Carcinoma - drug therapy</subject><subject>Humans</subject><subject>immune checkpoint inhibitors</subject><subject>Monoclonal antibodies</subject><subject>Ro‐52</subject><subject>Squamous cell carcinoma</subject><subject>Stevens-Johnson Syndrome - etiology</subject><subject>Toxic epidermal necrolysis</subject><issn>0105-1873</issn><issn>1600-0536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1OwzAURi0EoqUw8ALIEhND2us4dpsRlV-pUpcyR47tlFRx3NqNoEx9EHi5PgmmKWzc5S7n-67uQeiSQJ-EGUir-iQhw_QIdQkHiIBRfoy6QIBFZDSkHXTm_QKA8CQenaIOZUMeU0i6aDW2xuh6jW2Nd9vPmX0vJdbLUmlnRIVrLZ2tNr70WDWurOdYCuN0VX40RuR47bRY7-OFddhqb5evYq5D0K8aYWzjsdRVFUJOlrU1Yrf9Okcnhai8vjjsHnp5uJ-Nn6LJ9PF5fDuJJGU0jXKeFlRCQSHOGSFCcs04V1JxQjkHQXOVxDIFBTmNCQHBqKJMkBwKRnMtaQ9dt71LZ1eN9utsYRtXh5NZPCTBRRAAgbppqfCn904X2dKVRrhNRiD7kZsFudlebmCvDo1NbrT6I39tBmDQAm9lpTf_N2Xj6V1b-Q1ny4bR</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Ruan, Yeping</creator><creator>Shih, Yanting</creator><creator>Chen, Shile</creator><creator>Xia, Qunli</creator><creator>Zhao, Xiaoqing</creator><creator>Cao, Hua</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-9232-1412</orcidid><orcidid>https://orcid.org/0000-0001-5908-6206</orcidid><orcidid>https://orcid.org/0000-0001-8090-0647</orcidid><orcidid>https://orcid.org/0000-0001-5548-5883</orcidid><orcidid>https://orcid.org/0000-0002-3825-9662</orcidid><orcidid>https://orcid.org/0000-0001-8550-8767</orcidid></search><sort><creationdate>202210</creationdate><title>Comment on “Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma”</title><author>Ruan, Yeping ; Shih, Yanting ; Chen, Shile ; Xia, Qunli ; Zhao, Xiaoqing ; Cao, Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3539-b69f3c0f302b511ac6e566dcd613660a3bd42c90d0b32110a53d35a1b0f53bec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Monoclonal, Humanized</topic><topic>anti‐PD1 immunotherapy</topic><topic>anti‐SSA antibody</topic><topic>Dermatitis, Allergic Contact</topic><topic>Esophageal Neoplasms - drug therapy</topic><topic>Esophageal Squamous Cell Carcinoma - drug therapy</topic><topic>Humans</topic><topic>immune checkpoint inhibitors</topic><topic>Monoclonal antibodies</topic><topic>Ro‐52</topic><topic>Squamous cell carcinoma</topic><topic>Stevens-Johnson Syndrome - etiology</topic><topic>Toxic epidermal necrolysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ruan, Yeping</creatorcontrib><creatorcontrib>Shih, Yanting</creatorcontrib><creatorcontrib>Chen, Shile</creatorcontrib><creatorcontrib>Xia, Qunli</creatorcontrib><creatorcontrib>Zhao, Xiaoqing</creatorcontrib><creatorcontrib>Cao, Hua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Contact dermatitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ruan, Yeping</au><au>Shih, Yanting</au><au>Chen, Shile</au><au>Xia, Qunli</au><au>Zhao, Xiaoqing</au><au>Cao, Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comment on “Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma”</atitle><jtitle>Contact dermatitis</jtitle><addtitle>Contact Dermatitis</addtitle><date>2022-10</date><risdate>2022</risdate><volume>87</volume><issue>4</issue><spage>387</spage><epage>388</epage><pages>387-388</pages><issn>0105-1873</issn><eissn>1600-0536</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>35762304</pmid><doi>10.1111/cod.14179</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9232-1412</orcidid><orcidid>https://orcid.org/0000-0001-5908-6206</orcidid><orcidid>https://orcid.org/0000-0001-8090-0647</orcidid><orcidid>https://orcid.org/0000-0001-5548-5883</orcidid><orcidid>https://orcid.org/0000-0002-3825-9662</orcidid><orcidid>https://orcid.org/0000-0001-8550-8767</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0105-1873 |
| ispartof | Contact dermatitis, 2022-10, Vol.87 (4), p.387-388 |
| issn | 0105-1873 1600-0536 |
| language | eng |
| recordid | cdi_proquest_journals_2710012300 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Antibodies, Monoclonal, Humanized anti‐PD1 immunotherapy anti‐SSA antibody Dermatitis, Allergic Contact Esophageal Neoplasms - drug therapy Esophageal Squamous Cell Carcinoma - drug therapy Humans immune checkpoint inhibitors Monoclonal antibodies Ro‐52 Squamous cell carcinoma Stevens-Johnson Syndrome - etiology Toxic epidermal necrolysis |
| title | Comment on “Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma” |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A24%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comment%20on%20%E2%80%9CToxic%20epidermal%20necrolysis%20during%20camrelizumab%20treatment%20for%20oesophageal%20squamous%20cell%20carcinoma%E2%80%9D&rft.jtitle=Contact%20dermatitis&rft.au=Ruan,%20Yeping&rft.date=2022-10&rft.volume=87&rft.issue=4&rft.spage=387&rft.epage=388&rft.pages=387-388&rft.issn=0105-1873&rft.eissn=1600-0536&rft_id=info:doi/10.1111/cod.14179&rft_dat=%3Cproquest_cross%3E2710012300%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2710012300&rft_id=info:pmid/35762304&rfr_iscdi=true |